Medical Education Library

Update On Insulin Management in Type 2 Diabetes

May 2012 ยท Vol. 61, No. 05 Suppl: S2-S2
This supplement was sponsored by the Primary Care Metabolic Group and the Primary Care Education Consortium and is supported by funding from Novo Nordisk Inc. It was edited and peer reviewed by The Journal of Family Practice.
PDF Download

 

Insulin has been a cornerstone of therapy for diabetes mellitus since its discovery a century ago. The insulin analog formulations available today are vastly improved over the animal-derived insulins used for decades; pens and other devices used to administer insulin are also vastly improved. Further clinical benefits may be possible with insulins expected to be available in the near future, such as insulin degludec. There are many challenges with insulin therapy in the primary care setting, but strategies can be employed to address patient barriers, as well as to initiate and modify insulin therapy based upon patient response.

Recommended Reading

Physicians Integral in Battling Diabetes Epidemic
MDedge Family Medicine
Bariatric Surgery Bests Medication In Obese Diabetics
MDedge Family Medicine
New Warning, Contraindications Announced for Aliskiren-Containing Drugs
MDedge Family Medicine
Study Looks at Cost of Lowering HbA1c Cutoffs
MDedge Family Medicine
Insulin Degludec Matches Insulin Glargine Efficacy
MDedge Family Medicine
Health care models for treatment and management of diabetes
MDedge Family Medicine
Introduction
MDedge Family Medicine
Traditional or centralized models of diabetes care: The multidisciplinary diabetes team approach
MDedge Family Medicine
Diabetes and alcohol use: Detecting at-risk drinking
MDedge Family Medicine
The work-up for mixed hyperlipidemia: A case study
MDedge Family Medicine